Real World Evidence on the Safety of the Adjuvanted Recombinant Zoster Vaccine in Patients with Rheumatic Diseases Preliminary Results from a Prospective Multicenter Observational Greek Study

Authors
Category Primary study
ConferenceACR Convergence 2024
Year 2024
This article has no abstract
Epistemonikos ID: a38d65885a3577fef4036bd89e02043a0a4a7555
First added on: Feb 21, 2026